• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET 360 NANO 2MM X 4CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET 360 NANO 2MM X 4CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Model Number M0035442040
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/10/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Due to the automated mes (manufacturing execution system) system there are controls in the manufacturing process to ensure the product met specifications upon release.During visual inspection, the coil delivery wire was only returned, the main coil was found to be detached and not returned.The detachment seems to be mechanical, and the coil delivery wire was found to be kinked/bent.Functional test was unable to perform due to coil damage.The reported can be confirmed as the analysis results are consistent with the reported event.The device failed to meet specifications when received for complaint investigation, based on the damage noted to the device.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.Additional information provided by the customer that no damage noted to the packaging prior to opening the packaging.Also, device prepared for use as per the directions for use and continuous flush was set up and maintained throughout the clinical procedure.The patient¿s anatomy was described as moderately tortuous.The device delivery wire was not returned, the coil had been mechanically detached from the delivery wire and the delivery wire was kinked.It is probable that the delivery was kinked, and the main coil was prematurely detached inside the microcatheter due to the reported coil jamming.An assignable cause of procedural factors will be assigned to the reported ¿coil jammed¿ and to the analyzed ¿coil delivery wire kinked/bent¿ and ¿main coil prematurely detached/separated during use¿, as the issue is associated with a product that meets stryker design and manufacture specifications and was used in according with the dfu but due to procedural and/or anatomical factors during use, the product performance was limited.
 
Event or Problem Description
Analysis of the returned device found the main coil prematurely detached/separated during use.There were no clinical consequences to the patient reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET 360 NANO 2MM X 4CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
MDR Report Key12544238
Report Number3008881809-2021-00401
Device Sequence Number3420128
Product Code HCG
UDI-Device Identifier07613252600299
UDI-Public07613252600299
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K153658
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source distributor
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/02/2023
Device Model NumberM0035442040
Device Catalogue NumberM0035442040
Device Lot Number22541438
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/01/2021
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/22/2021
Initial Report FDA Received Date09/28/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-